Tvardi Therapeutics Inc (TVRD) Straddle

Trading a TVRD straddle lets you take a pure volatility position on Tvardi Therapeutics Inc without committing to a direction. Tvardi Therapeutics Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate TVRD straddle pricing in real time and find the moments when expected moves are mispriced.

A long straddle on TVRD profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Tvardi Therapeutics Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the TVRD straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.

Tvardi Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need. Their lead candidate, TTI-101, is currently in Phase 2 clinical trials for idiopathic pulmonary fibrosis (IPF) and hepatocellular carcinoma (HCC).

Earnings, product cycles, macro prints — any time volatility itself is the trade, the TVRD straddle is the cleanest expression of that view. Our scanner prices every TVRD straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a TVRD straddle into a catalyst or short a TVRD straddle to harvest decay, the options straddle setups that matter are all in one place.